Finance

Lists
600833:SHA
Shanghai No.1 Pharmacy Co Ltd
CNÂ¥10.67
+0.47%
(+0.050) 1D
Sep 7, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600833...
Open
CNÂ¥10.66
High
CNÂ¥10.73
Low
CNÂ¥10.56
Mkt. cap
2.37B
Avg. vol.
12.01M
Volume
3.97M
Dividend
0.73%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 26, 2026
P/E ratio
34.06
52-wk high
CNÂ¥15.55
52-wk low
CNÂ¥8.83
EPS
CNÂ¥0.31
Shares outstanding
223.09M
No. of employees
818
Open
CNÂ¥10.66
High
CNÂ¥10.73
Low
CNÂ¥10.56
Mkt. cap
2.37B
Avg. vol.
12.01M
Volume
3.97M
Dividend
0.73%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 26, 2026
P/E ratio
34.06
52-wk high
CNÂ¥15.55
52-wk low
CNÂ¥8.83
EPS
CNÂ¥0.31
Shares outstanding
223.09M
No. of employees
818
About Shanghai No.1 Pharmacy Co Ltd
CEO-
Employees818
FoundedSep 23, 1992
Headquarters-
SectorDrug
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
542.48M
591.16M
484.56M
497.01M
Cost of goods sold
456.34M
501.71M
413.36M
418.27M
Cost of revenue
456.34M
501.71M
413.36M
418.27M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85.76M
89.74M
72.40M
82.18M
Operating expense
86.94M
93.69M
72.76M
84.48M
Total operating expenses
543.28M
595.40M
486.12M
502.75M
Operating income
-795.06K
-4.25M
-1.56M
-5.73M
Other non operating income
-841.60K
232.61K
-117.44K
352.54K
EBT including unusual items
52.37M
5.93M
30.96M
3.05M
EBT excluding unusual items
1.25M
-1.22M
1.45M
1.58M
Income tax expense
12.68M
1.41M
7.30M
214.41K
Effective tax rate
24.20%
23.82%
23.57%
7.04%
Other operating expenses
1.28M
2.02M
994.91K
1.05M
Net income
39.25M
4.48M
23.26M
2.91M
Net profit margin
7.23%
0.76%
4.80%
0.58%
Earnings per share
-
-
-
-
Interest and investment income
4.07M
5.41M
3.95M
7.63M
Interest expense
-1.11M
-1.02M
-815.89K
-668.37K
Net interest expenses
2.96M
4.39M
3.13M
6.96M
Depreciation and amortization charges
-
-
-
-
EBITDA
819.56K
-2.43M
252.64K
-3.69M
Gain or loss from assets sale
404.94K
-50.18M
-
-30.73M
AI content may include mistakes. Learn more
Google apps